Hudson Valley Investment Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.14M | Hold |
11,000
| – | – | 0.26% | 79 |
|
|
2026
Q1 | $2.47M | Hold |
11,000
| – | – | 0.32% | 74 |
|
|
2025
Q4 | $2.65M | Hold |
11,000
| – | – | 0.29% | 76 |
|
|
2025
Q3 | $3.01M | Hold |
11,000
| – | – | 0.31% | 78 |
|
|
2025
Q2 | $2.84M | Hold |
11,000
| – | – | 0.31% | 79 |
|
|
2025
Q1 | $2.46M | Hold |
11,000
| – | – | 0.29% | 72 |
|
|
2024
Q4 | $2.52M | Hold |
11,000
| – | – | 0.28% | 75 |
|
|
2024
Q3 | $2.69M | Hold |
11,000
| – | – | 0.3% | 73 |
|
|
2024
Q2 | $1.9M | Hold |
11,000
| – | – | 0.25% | 81 |
|
|
2024
Q1 | $2.18M | Hold |
11,000
| – | – | 0.26% | 78 |
|
|
2023
Q4 | $1.9M | Sell |
11,000
-18
| -0.2% | -$2.77K | 0.26% | 82 |
|
|
2023
Q3 | $1.63M | Hold |
11,018
| – | – | 0.23% | 85 |
|
|
2023
Q2 | $2.41M | Hold |
11,018
| – | – | 0.33% | 80 |
|
|
2023
Q1 | $2.41M | Hold |
11,018
| – | – | 0.34% | 82 |
|
|
2022
Q4 | $2.29M | Hold |
11,018
| – | – | 0.35% | 82 |
|
|
2022
Q3 | $2.4M | Hold |
11,018
| – | – | 0.39% | 71 |
|
|
2022
Q2 | $2.31M | Buy |
11,018
+18
| +0.2% | +$3.83K | 0.36% | 76 |
|
|
2022
Q1 | $2.67M | Hold |
11,000
| – | – | 0.36% | 77 |
|
|
2021
Q4 | $2.87M | Hold |
11,000
| – | – | 0.45% | 56 |
|
|
2021
Q3 | $2.9M | Hold |
11,000
| – | – | 0.5% | 54 |
|
|
2021
Q2 | $2.71M | Sell |
11,000
-9,098
| -45% | -$1.91M | 0.47% | 57 |
|
|
2021
Q1 | $3.04M | Sell |
20,098
-328
| -2% | -$65.8K | 0.54% | 54 |
|
|
2020
Q4 | $3.2M | Sell |
20,426
-5,354
| -21% | -$1.07M | 0.61% | 50 |
|
|
2020
Q3 | $2.96M | Sell |
25,780
-608
| -2% | -$112K | 0.64% | 48 |
|
|
2020
Q2 | $3.04M | Sell |
26,388
-3,791
| -13% | -$620K | 0.71% | 46 |
|
|
2020
Q1 | $2.63M | Sell |
30,179
-14,398
| -32% | -$2.29M | 0.73% | 45 |
|
|
2019
Q4 | $6.48M | Buy |
44,577
+223
| +0.5% | +$32.1K | 1.38% | 19 |
|
|
2019
Q3 | $5.46M | Sell |
44,354
-903
| -2% | -$118K | 1.27% | 22 |
|
|
2019
Q2 | $5.51M | Buy |
45,257
+183
| +0.4% | +$20.3K | 1.28% | 23 |
|
|
2019
Q1 | $4.91M | Sell |
45,074
-4,270
| -9% | -$441K | 1.19% | 26 |
|
|
2018
Q4 | $5.22M | Sell |
49,344
-13,429
| -21% | -$1.44M | 1.2% | 25 |
|
|
2018
Q3 | $7.8M | Buy |
62,773
+1,799
| +3% | +$197K | 1.81% | 14 |
|
|
2018
Q2 | $6.32M | Buy |
60,974
+1,301
| +2% | +$132K | 1.55% | 16 |
|
|
2018
Q1 | $6.54M | Buy |
59,673
+1,544
| +3% | +$146K | 1.65% | 16 |
|
|
2017
Q4 | $6.04M | Buy |
58,129
+365
| +0.6% | +$30.2K | 1.49% | 16 |
|
|
2017
Q3 | $5.78M | Sell |
57,764
-800
| -1% | -$61.2K | 1.5% | 15 |
|
|
2017
Q2 | $5.55M | Buy |
58,564
+245
| +0.4% | +$17.5K | 1.53% | 13 |
|
|
2017
Q1 | $5.01M | Sell |
58,319
-850
| -1% | -$58.7K | 1.4% | 21 |
|
|
2016
Q4 | $4.29M | Buy |
59,169
+1,169
| +2% | +$71.6K | 1.26% | 22 |
|
|
2016
Q3 | $4.06M | Buy |
58,000
+609
| +1% | +$40.5K | 1.26% | 23 |
|
|
2016
Q2 | $3.74M | Sell |
57,391
-6,744
| -11% | -$398K | 1.2% | 26 |
|
|
2016
Q1 | $4.32M | Buy |
64,135
+7,380
| +13% | +$418K | 1.4% | 21 |
|
|
2015
Q4 | $3.89M | Sell |
56,755
-7,605
| -12% | -$429K | 1.21% | 27 |
|
|
2015
Q3 | $3.83M | Buy |
64,360
+9,210
| +17% | +$496K | 1.24% | 26 |
|
|
2015
Q2 | $3.22M | Buy |
55,150
+35,150
| +176% | +$2.22M | 1.01% | 36 |
|
|
2015
Q1 | $1.44M | Buy |
+20,000
| New | +$1.3M | 0.49% | 59 |
|
|
2013
Q3 | – | Sell |
-9,000
| Closed | -$406K | – | 125 |
|
|
2013
Q2 | $406K | Buy |
+9,000
| New | +$427K | 0.19% | 84 |
|
Other funds holding RMD
TIA
WF
VF
AT
AS
TIM
Hudson Valley Investment Advisors's RMD Position: Q2 2026 in Review
Hudson Valley Investment Advisors held its ResMed (RMD) position steady in Q2 2026 at 11,000 shares worth $2.14M. The position accounts for 0.26% of the portfolio, ranked #79.
Hudson Valley Investment Advisors first reported a position in RMD in Q2 2013 and has held it in 47 quarters since. The position peaked at $7.8M in Q3 2018. 319 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Hudson Valley Investment Advisors held 11,000 shares of ResMed worth $2.14M as of Q2 2026.
- Hudson Valley Investment Advisors left its ResMed share count unchanged in Q2 2026.
- ResMed made up 0.26% of Hudson Valley Investment Advisors's portfolio in Q2 2026, its #79 holding.
- Hudson Valley Investment Advisors first reported a position in ResMed in Q2 2013 and has held it in 47 quarters since.
- Hudson Valley Investment Advisors's ResMed position peaked at $7.8M in Q3 2018.
- 319 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Hudson Valley Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.